Victor Sandor - Net Worth and Insider Trading
Victor Sandor Net Worth
The estimated net worth of Victor Sandor is at least $8 Million dollars as of 2024-11-13. Victor Sandor is the Chief Medical Officer of Array BioPharma Inc and owns about 209,543 shares of Array BioPharma Inc (ARRY) stock worth over $8 Million. Victor Sandor is also the Director of ADC Therapeutics SA and owns about 80,886 shares of ADC Therapeutics SA (ADCT) stock worth over $236,996. Details can be seen in Victor Sandor's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Victor Sandor has not made any transactions after 2024-06-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Victor Sandor
Victor Sandor Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Victor Sandor owns 3 companies in total, including Prelude Therapeutics Inc (PRLD) , Merus NV (MRUS) , and Kymera Therapeutics Inc (KYMR) .
Click here to see the complete history of Victor Sandor’s form 4 insider trades.
Insider Ownership Summary of Victor Sandor
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PRLD | Prelude Therapeutics Inc | 2020-09-24 | director |
| MRUS | Merus NV | 2021-05-28 | director |
| KYMR | Kymera Therapeutics Inc | 2022-11-03 | director |
Victor Sandor Latest Holdings Summary
Victor Sandor currently owns a total of 2 stocks. Among these stocks, Victor Sandor owns 209,543 shares of Array BioPharma Inc (ARRY) as of June 4, 2019, with a value of $8 Million and a weighting of 97.18%. Victor Sandor also owns 80,886 shares of ADC Therapeutics SA (ADCT) as of June 17, 2024, with a value of $236,996 and a weighting of 2.82%.
Latest Holdings of Victor Sandor
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARRY | Array BioPharma Inc | 2019-06-04 | 209,543 | 38.95 | 8,161,700 |
| ADCT | ADC Therapeutics SA | 2024-06-17 | 80,886 | 2.93 | 236,996 |
Holding Weightings of Victor Sandor
Victor Sandor Form 4 Trading Tracker
According to the SEC Form 4 filings, Victor Sandor has made a total of 0 transactions in Array BioPharma Inc (ARRY) over the past 5 years. The most-recent trade in Array BioPharma Inc is the sale of 100,000 shares on June 4, 2019, which brought Victor Sandor around $3 Million.
According to the SEC Form 4 filings, Victor Sandor has made a total of 1 transactions in ADC Therapeutics SA (ADCT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in ADC Therapeutics SA is the sale of 6,995 shares on June 17, 2024, which brought Victor Sandor around $20,216.
Insider Trading History of Victor Sandor
- 1
Victor Sandor Trading Performance
Victor Sandor Ownership Network
Ownership Network List of Victor Sandor
Ownership Network Relation of Victor Sandor
Victor Sandor Owned Company Details
What does Prelude Therapeutics Inc do?
Who are the key executives at Prelude Therapeutics Inc?
Victor Sandor is the director of Prelude Therapeutics Inc. Other key executives at Prelude Therapeutics Inc include director & President & CEO Krishna Vaddi , Chief Legal Counsel & Corp Sec. Bryant David Lim , and Chief Financial Officer Laurent Chardonnet .
Prelude Therapeutics Inc (PRLD) Insider Trades Summary
Over the past 18 months, Victor Sandor made no insider transaction in Prelude Therapeutics Inc (PRLD). Other recent insider transactions involving Prelude Therapeutics Inc (PRLD) include a net purchase of 13,756 shares made by Krishna Vaddi , a net purchase of 869,565 shares made by Orbimed Advisors Llc , and a net purchase of 869,565 shares made by David P Bonita .
In summary, during the past 3 months, insiders sold 0 shares of Prelude Therapeutics Inc (PRLD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Prelude Therapeutics Inc (PRLD) were sold and 1,760,286 shares were bought by its insiders, resulting in a net purchase of 1,760,286 shares.
Prelude Therapeutics Inc (PRLD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Prelude Therapeutics Inc Insider Transactions
Victor Sandor Mailing Address
Above is the net worth, insider trading, and ownership report for Victor Sandor. You might contact Victor Sandor via mailing address: C/o Array Biopharma Inc., 3200 Walnut Street, Boulder Co 80301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
